Patents by Inventor Terence Shau Yin WAI

Terence Shau Yin WAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210401952
    Abstract: The invention provides a method for treating acute myeloid leukemia (AML) in a subject in need thereof, said method comprising administering a therapeutically effective amount of an arginine-depleting agent to the subject, wherein the AML is of the French-American-British (FAB) subtype M0 (undifferentiated acute myeloblastic leukemia), M2 (acute myeloblastic leukemia with maturation), M4 (acute myeloblastic leukemia with maturation), M4 eos (acute myelomonocytic leukemia with eosinophilia), M5 (acute monocytic leukemia), M6 (acute erythroid leukemia) or M7 (acute megakaryoblastic leukemia).
    Type: Application
    Filed: June 29, 2020
    Publication date: December 30, 2021
    Inventors: Sui-Yi KWOK, Norman Fung-Man WAI, Terence Shau Yin WAI, Yun Chung LEUNG
  • Patent number: 10946099
    Abstract: The invention relates to pharmaceutical compositions comprising a conjugate of a porphyrin (e.g., PpIX) and a recombinant protein. The pharmaceutical compositions of the invention may be used in photodynamic therapy. The invention also relates to methods of producing such pharmaceutical compositions and to methods of using such pharmaceutical compositions in the treatment of diseases, such as cancer.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: March 16, 2021
    Assignee: VISION GLOBAL HOLDINGS LIMITED
    Inventors: Sui Yi Kwok, Norman Fung Man Wai, Terence Shau Yin Wai, Shan Yu
  • Patent number: 10752672
    Abstract: The present disclosure relates to recombinant hemoglobins with improved oxygen carrying capacity and methods of preparation and use thereof. The present disclosure also relates to a pharmaceutical composition including the recombinant hemoglobin useful for treating oxygen deficiency related diseases or conditions, such as stroke, hemorrhagic shock, peripheral arterial disease (PAD), acute mountain sickness (AMS), cancer, and Parkinson's disease (PD).
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: August 25, 2020
    Assignee: Cheer Global Limited
    Inventors: Sui Yi Kwok, Norman Fung Man Wai, Shan Yu, Terence Shau Yin Wai
  • Publication number: 20200247877
    Abstract: The present disclosure relates to recombinant hemoglobins with improved oxygen carrying capacity and methods of preparation and use thereof. The present disclosure also relates to a pharmaceutical composition including the recombinant hemoglobin useful for treating oxygen deficiency related diseases or conditions, such as stroke, hemorrhagic shock, peripheral arterial disease (PAD), acute mountain sickness (AMS), cancer, and Parkinson's disease (PD).
    Type: Application
    Filed: January 31, 2020
    Publication date: August 6, 2020
    Inventors: Sui Yi KWOK, Norman Fung Man WAI, Shan YU, Terence Shau Yin WAI
  • Publication number: 20190054173
    Abstract: The invention relates to pharmaceutical compositions comprising a conjugate of a porphyrin (e.g., PpIX) and a recombinant protein. The pharmaceutical compositions of the invention may be used in photodynamic therapy. The invention also relates to methods of producing such pharmaceutical compositions and to methods of using such pharmaceutical compositions in the treatment of diseases, such as cancer.
    Type: Application
    Filed: June 27, 2018
    Publication date: February 21, 2019
    Applicant: VISION GLOBAL HOLDINGS LIMITED
    Inventors: Sui Yi KWOK, Norman Fung Man WAI, Terence Shau Yin WAI, Shan YU